10:00 - 14:00
CST
Winnipeg MB
Canada
In-person event
Winnipeg Blood Cancer Connect & Learn
An in-person education event – Winnipeg, Manitoba
Canad Inns – Polo Park (1405 St. Matthews Ave Winnipeg)
Join the Leukemia & Lymphoma Society of Canada (LLSC) at our upcoming Winnipeg blood cancer conference. This free event is offered to blood cancer patients, survivors, caregivers, family members to learn more about:
- CAR-T therapy comes to Manitoba - Dr. Ivan Landego
- Pain management strategies during and after cancer treatment - Dr. Paul Daeninck
- Complementary and integrative medicine - Dr. Lynda Balneaves
A brunch will be served.
Agenda
| 9:30 am - 10:00 am | Arrival, registration, and beverages |
| 10:00 am - 10:15 am | Opening remarks |
| 10:15 am - 11:15 am | CAR-T therapy comes to Manitoba - Dr. Ivan Landego |
| 11:15 am – 12:15 pm | Complementary and integrative medicine: What you need to know - Dr. Lynda Balneaves |
| 12:15 pm – 12:45 pm | Brunch Break and networking |
| 12:45 pm – 1:45 pm | Pain management strategies during and after cancer treatment - Dr. Paul Daeninck |
| 1:45 pm – 2:00 pm | Closing remarks |
Dr. Ivan Landego
Dr. Ivan Landego is a member of the Department of Internal Medicine, Rady Faculty of Health Sciences, Section of Medical Oncology and Hematology, at the University of Manitoba. His primary area of interest is immune therapies for lymphoproliferative disorders, including bispecific antibodies, checkpoint inhibitors, cellular therapeutics, and bone marrow transplantation.
Dr. Paul Daeninck
Dr. Paul Daeninck is a medical oncologist and palliative medicine consultant connected with CancerCare Manitoba, the Rady College of Medicine, and the WRHA. He is actively involved in education of medical professionals and has ongoing clinical and academic interests in palliative medicine, cannabinoids, and psychedelic-assisted therapy.
Dr. Lynda Balneaves
Dr. Balneaves is a Full Professor and Associate Dean, Research in the College of Nursing, Rady Faculty of Health Sciences at the University of Manitoba. Previously, she has held academic positions at the University of Toronto and the University of British Columbia. Her research program has focused on the use of complementary therapies in the context of cancer and the development and evaluation of knowledge translation and decision support intervention.
This event was made possible thanks to the support of:
